YOKOHAMA CITY UNIVERSITY MEDICAL CENTER
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1871-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
141
Active:0
Completed:113
Trial Phases
5 Phases
Phase 1:1
Phase 2:23
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (135 trials with phase data)• Click on a phase to view related trials
Not Applicable
102 (75.6%)Phase 2
23 (17.0%)Phase 4
8 (5.9%)Phase 1
1 (0.7%)Phase 3
1 (0.7%)Trimethylamine N-oxide in Myocardial Infarction
Completed
- Conditions
- Myocardial Infarction
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 112
- Registration Number
- NCT03418285
Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran
- First Posted Date
- 2015-01-06
- Last Posted Date
- 2015-08-06
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT02331602
- Locations
- 🇯🇵
Ashigara Kami Hospital, Ashigaura, Kanagawa, Japan
🇯🇵Chigasaki Municipal Hospital, Chigasaki, Kanagawa, Japan
🇯🇵Fujisawa City Hospital, Fujisawa, Kanagawa, Japan
the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT02279342
- Locations
- 🇯🇵
Yokohama City University Medical Center, Yokohama, Kanagawa, Japan
Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
- Conditions
- The Injection Burden
- Interventions
- Drug: IVA group
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT02126904
- Locations
- 🇯🇵
Yokohama City University Medical Center, Yokohama, Kanagawa, Japan
Endothelial Dysfunction and Plaque Vulnerability
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2012-04-17
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- Yokohama City University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01578616
- Locations
- 🇯🇵
Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found